2228 ⎘
Animals characterised by purpose; Animal model, e.g. for test or diseases Animal model comprising a reporter system for screening tests
Mouse Model For Alzheimer's Disease And Neurofibrillary Pathology
#2GENETICALLY ENGINEERED MICE MODELS FOR MULTIPLE MYELOMA
#3ZEBRAFISH MODEL OF HUMAN ACUTE MYELOID LEUKEMIA AND METHOD OF USE THEREOF
#4TRANSGENIC ANIMAL PHENOTYPING PLATFORM AND USES THEREOF
#5TRANSGENIC MOUSE MODELS OF HUMAN ADAPTIVE AND INNATE IMMUNITY AND METHODS OF USE
#6ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN EXCITATORY CORTICAL NEURONS
#7TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
#8PROTEINS WITH CARDIOPROTECTIVE ACTIVITY
#9ANIMAL MODEL FOR DISEASES ASSOCIATED WITH ABSENCE OR REDUCTION OF SOCIAL DOMINANCE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES
#10METHOD FOR PRODUCING RECOMBINANT PROTEINS IN INSECTS
#11POLY-GLUTAMINE ANDROGEN RECEPTOR KNOCK-IN ANIMAL MODELS, REAGENTS AND METHODS
#12Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#13A METHOD FOR CONSTRUCTING A COFILIN-1 TRANSGENIC MODEL AND USE THEREOF
#14COMPOSITION FOR PREVENTION OR TREATMENT OF KIDNEY DISEASE
#15CAS-READY MOUSE EMBRYONIC STEM CELLS AND MICE AND USES THEREOF
#16CHIMERIC SENSOR PROTEIN AND METHODS OF USE THEREOF
#17BIOSENSORS FOR DETECTING CHANGES IN THE LEVEL OF A NEUROTRANSMITTER IN THE CENTRAL NERVOUS SYSTEM
#18TRANSGENIC ANIMAL PHENOTYPING PLATFORM AND USES THEREOF
#19MOTOR NEURON-SPECIFIC EXPRESSION VECTORS
#20TRANSGENIC FLUORESCENT ORNAMENTAL AMPHIBIANS
#21MODEL ORGANISMS HUMANIZED FOR DRUG DISCOVERY AND SCREENING
#22LINCRNA-DEFICIENT NON-HUMAN ANIMALS
#23ANASTASIS BIOSENSOR
#24TREATMENT OF EXCESSIVE NEOVASCULARIZATION
#25MONOGENIC OR POLYGENIC DISEASE MODEL ORGANISMS HUMANIZED WITH TWO OR MORE GENES
#26NON-HUMAN ANIMAL SECRETOME MODELS
#27MICROFLUIDIC DEVICE, SYSTEM AND METHODS THEREOF FOR MEASURING AND RECORDING ELECTRICAL SIGNALS FROM A POOL OF MULTIPLE NEMATODES
#28Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis (ALS) by UPF2
#29METHODS AND COMPOSITIONS FOR BINDING IMMUNOGLOBULIN PROTEIN TARGETING
#30Humanized IL-4 and IL-4Rα animals
#31COMPOSITIONS AND METHODS FOR DETECTING NUCLEIC ACID-PROTEIN INTERACTIONS
#32Proteins with cardioprotective activity
#33AUXIN-INDUCIBLE DEGRON SYSTEM KIT AND USE THEREOF
#34NONHUMAN ANIMAL AND USE FOR SAME
#35ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF
#36CHIMERIC GENE CONSTRUCTS FOR GENERATION OF FLUORESCENT TRANSGENIC ORNAMENTAL FISH
#37ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN SELECTED NEURONAL CELL POPULATIONS
#38NUCLEIC ACID-BINDING PROTEIN
#39PROTEINS WITH CARDIOPROTECTIVE ACTIVITY
#40Targeting Vector, Nucleic Acid Composition, and Method for Constructing Liver-injured Mouse Model
#41USE OF NEUROPILIN-1 (NRP1) AS A CELL SURFACE MARKER FOR ISOLATING HUMAN CARDIAC VENTRICULAR PROGENITOR CELLS
#42TRANSGENIC MODELS FOR STEM CELL THERAPIES
#43Complement Factor H Gene Knockout Rat as a Model of C3 Glomerulopathy
#44ANIMAL MODEL FOR AMPLIFYING HUMAN OR ANIMAL CIRCULATING TUMOR CELLS
#45COMPOSITIONS AND METHODS RELATED TO REPORTER SYSTEMS AND LARGE ANIMAL MODELS FOR EVALUATING GENE EDITING TECHNOLOGY
#46ARTIFICIAL EXPRESSION CONSTRUCTS FOR SELECTIVELY MODULATING GENE EXPRESSION IN EXCITATORY CORTICAL NEURONS
#47NON-HUMAN ANIMAL EXHIBITING DIMINISHED UPPER AND LOWER MOTOR NEURON FUNCTION AND SENSORY PERCEPTION
#48Cas-ready mouse embryonic stem cells and mice and uses thereof
#49Humanized IL-4 and IL-4Rα animals
#50CD31SHED AS A MOLECULAR TARGET FOR IMAGING OF INFLAMMATION
#51Non-human animals models of retinoschisis
#52METHODS AND COMPOSITIONS FOR ASSESSING CRISPR/CAS-MEDIATED DISRUPTION OR EXCISION AND CRISPR/CAS-INDUCED RECOMBINATION WITH AN EXOGENOUS DONOR NUCLEIC ACID IN VIVO
#53Isolated liver cancer stem cell and method for drug screening thereof
#54INDUCIBLE MODIFICATION OF A CELL GENOME
#55TARGETED TREATMENT OF LEBER CONGENITAL AMOUROSIS
#56Method for producing recombinant proteins in insects
#57Control and Characterization of Psychotic States
#58Targeted delivery of glycine receptors to excitable cells
#59Mutations in rhodopsin gene in zebrafish and uses thereof
#60METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATIONS AND METHODS OF USE
#61CANCER IMAGING WITH THERAPY: THERANOSTICS
#62MRGPRX2/MRGPRB2 EXPRESSING CELL BASED ASSAY TO DETECT PSEUDO-ALLERGIC DRUG REACTIONS AND TO IDENTIFY BLOCKERS TO PREVENT THE ADVERSE REACTIONS
#63Motor neuron-specific expression vectors
#64Method to Implement a CRISPR Gene Drive in Mammals
#65Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#66METHODS FOR GENDER DETERMINATION OF AVIAN EMBRYOS IN UNHATCHED EGGS AND MEANS THEREOF
#67INHIBITORS OF DIHYDROOROTATE DEHYDROGENASE
#68DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING A PRO-APOPTOTIC PROTEIN
#69System and method for tracking and scoring animal health and meat quality
#70Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1
#71COMPOSITIONS AND METHODS FOR CONTROLLING PAIN
#72Anti-tumor properties of Dickkopf 3b
#73MODEL SYSTEM FOR MITOCHONDRIAL DYSFUNCTION AND METHODS OF USING THE SAME
#74SCREENING FOR AGENTS THAT TARGET THE ACTIN CYTOSKELETON USING C. ELEGANS EXPOSED TO HEAT SHOCK
#75Transgenic biosensor
#76Transgenic animal phenotyping platform and uses thereof
#77METHODS OF A DROSOPHILA MODEL FOR CHRONIC MYELOID LEUKEMIA (CML) TREATMENT
#78Humanized IL-4 and IL-4Ra animals
#79Mapping a Functional Cancer Genome Atlas of Tumor Suppressors Using AAV-CRISPR Mediated Direct In Vivo Screening
#80EFFICIENT PROTEIN EXPRESSION IN VIVO USING MODIFIED RNA (MOD-RNA)
#81Microfluidic device, system and methods thereof for measuring and recording electrical signals from a pool of multiple nematodes
#82Anastasis biosensor
#83METHOD FOR ASSAYING GENETIC VARIANTS
#84Genetically modified non-human animal with human or chimeric SIRPa
#85Genetically modified non-human animal with human or chimeric OX40
#86DMD REPORTER MODELS CONTAINING HUMANIZED DUCHENNE MUSCULAR DYSTROPHY MUTATIONS
#87Genetically modified non-human animal with human or chimeric OX40
#88HUMANIZED IL-7 RODENTS
#89Biosensor exhibiting sensitivity to trinitrotoluene
#90GENETICALLY MODIFIED MOUSE MODEL FOR HUMAN HEPATOCYTE XENOTRANSPLANTATION
#91NON-HUMAN ANIMAL EXHIBITING DIMINISHED UPPER AND LOWER MOTOR NEURON FUNCTION AND SENSORY PERCEPTION
#92STORAGE OF PLATELETS
#93LIGHT-ACTIVATED CHIMERIC OPSINS AND METHODS OF USING THE SAME
#94BANK OF STEM CELLS FOR PRODUCING CELLS FOR TRANSPLANTATION HAVING HLA ANTIGENS MATCHING THOSE OF TRANSPLANT RECIPIENTS AND METHODS FOR MAKING AND USING SUCH A STEM CELL BANK
#95Non-human animals having a disruption in a C9ORF72 locus
#96Expression of neuropeptides
#97DEVICES, SYSTEMS AND METHODS FOR OPTOGENETIC MODULATION OF ACTION POTENTIALS IN TARGET CELLS
#98EFFICIENT PROTEIN EXPRESSION IN VIVO USING MODIFIED RNA (MOD-RNA)
#99INDICATOR STEM CELL LINE/LIVING ORGANISM (NON-HUMAN) AND A METHOD FOR DETECTION OF THE GENOTOXIC POTENTIAL OF AQUATIC SAMPLES OR AQUEOUS SOLUTIONS OF TEST COMPOUNDS
#100CD31 as a molecular target for imaging of inflammation
#101Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells
#102Compositions and methods for genetically modifying myosin phosphatase target subunit (Mypt1) gene for lowering blood pressure
#103METHODS AND COMPOSITIONS FOR ASSESSING CRISPR/CAS-INDUCED RECOMBINATION WITH AN EXOGENOUS DONOR NUCLEIC ACID IN VIVO
#104Cas-ready mouse embryonic stem cells and mice and uses thereof
#105Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo
#106Use of inhibitors of ADAM12 as adjuvants in tumor therapies
#107TREATMENT OF EXCESSIVE NEOVASCULARIZATION
#108Humanized IL-7 rodents
#109TRPV1 KNOCK-IN METHOD AND TRPV1 MICE FOR ADIPOSE TISSUE MODULATION
#110Mutations in rhodopsin gene in zebrafish and uses thereof
#111OPTICALLY-CONTROLLED CNS DYSFUNCTION
#112Methods of treating or preventing pruritis by blocking natriuretic polypeptide b
#113Inducible modification of a cell genome
#114Poly-glutamine androgen receptor knock-in mouse models, reagents and methods
#115Motor neuron-specific expression vectors
#116Non-human animal models of retinoschisis
#117Methods and compositions for targeted genetic modifications and methods of use
#118Isolated Populations of Female Germline Stem Cells and Cell Preparations and Compositions Thereof
#119Non-obese diabetes mice and its applications
#120Nucleic acid construct with a p16 promoter that causes a prodrug converting enzyme to be expressed specifically in senescent cells
#121Transgenic animal for visualization of ATP and use thereof
#122Targeted RNA knockdown and knockout by type III-A Csm complexes
#123METHODS AND MATERIALS FOR USING TRANSGENIC NON-HUMAN ANIMALS EXPRESSING SODIUM IODIDE SYMPORTER POLYPEPTIDES TO MONITOR PATHOLOGICAL PROCESSES, DISEASE PROGRESSION, OR THERAPEUTIC RESPONSES OVER TIME
#124Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#125Chimeric gene constructs for generation of fluorescent transgenic ornamental fish
#126Vectors and methods for targeted integration in loci comprising constitutively expressed genes
#127Light-activated chimeric opsins and methods of using the same
#128DNA knock-in system
#129Minimally-invasive and activity-dependent control of excitable cells
#130Optogenetic control of endothelial cells
#131Humanized IL-4 and IL-4Rα animals
#132ADAM12 inhibitors and their use against inflammation-induced fibrosis
#133Insect muscle actin promoter
#134METHOD OF REGULATING LIFESPAN USING TRANSGENIC CAENORHABDITIS ELEGANS
#135Transgenic mouse for the assessment of thyroid hormone (TH) action
#136Humanized IL-7 rodents
#137Humanized IL-4 and IL-4Rα animals
#138Genetically modified rat derived from rat embryonic stem cell
#139DNA knock-in system
#140Animal models, cell lines and methods for screening hepatitis C virus vaccines
#141MrgprX2/MrgprB2 expressing cell based assay to detect pseudo-allergic drug reactions and to identify blockers to prevent the adverse reactions
#142LIGHT-SENSITIVE ION-PASSING MOLECULES
#143Red genetically encoded calcium indicators and methods of use
#144ANIMAL MODEL FOR STUDYING COMPLEX HUMAN DISEASES
#145Targeted delivery of glycine receptors to excitable cells
#146Method for screening gene expression in lincRNA-deficient mice or rats
#147Humanized IL-7 rodents
#148Rodent model of prostate cancer
#149Transgenic mouse for determining the role of senescent cells in cancer
#150Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
#151Method for manufacturing transgenic caenorhabditis elegans with DNA methyltransferase and use thereof
#152Methods of treating or preventing pruritis by blocking natriuretic polypeptide B
#153Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#154METHOD FOR DISTINGUISHING SECRETORY GRANULES OF DIFFERENT AGES
#155Methods for testing anti-thrombotic agents
#156Non-human animals having a disruption in a C9ORF72 locus
#157Anti-tumor properties of Dickkopf 3b
#158CONTROL AND CHARACTERIZATION OF PSYCHOTIC STATES
#159STABILIZED STEP FUNCTION OPSIN PROTEINS AND METHODS OF USING THE SAME
#160Methods of identifying modulators of olfactory receptors
#161Optically-controlled CNS dysfunction
#162Animal model and method for studying gene-gene interactions
#163Light-sensitive ion-passing molecules
#164Non-human animal exhibiting diminished upper and lower motor neuron function and sensory perception
#165Light-activated chimeric opsins and methods of using the same
#166TRANSGENIC ANIMALS FOR IN VIVO IMAGING
#167T cell receptors that are specific to a fluorescent protein, transgenic animals and methods of their making, isolated T cells, and methods of use
#168Compositions and methods for controlling pain
#169Exogenous gene expression vector, transformant discrimination marker, and transformant
#170Red genetically encoded calcium indicators and methods of use
#171Method for measuring cell-to-cell transmission of α-synuclein aggregates using bimolecular fluorescence complementation system and method for screening a substance for preventing or treating neurodegenerative disease using the same
#172Tilapia () myosin light chain 3 promoter
#173INSECT MUSCLE ACTIN PROMOTER
#174Use of a truncated CCN1 promoter for cancer diagnostics, therapeutics and theranostics
#175Animal Model Expressing Luciferase under Control of the Myelin Basic Protein Promoter (MBP-luci) and Use of the Model for Bioluminescence In Vivo Imaging
#176Islet1 (ISl1) and hearing loss
#177Devices, systems and methods for optogenetic modulation of action potentials in target cells
#178Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
#179Light-activated chimeric opsins and methods of using the same
#180Methods for producing a mouse XY embryonic (ES) cell line capable of producing a fertile XY female mouse in an F0 generation
#181Designer circuit controlling diet-induced obesity
#182Humanized IL-4 and IL-4Ra animals
#183Humanized IL-4 and IL-4Rα animals
#184Regeneration of coronary artery by coronary endothelial specific progenitor cells
#185Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor
#186Methods of reducing TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis by a UPF1 polypeptide or polynucleotide
#187Red transgenic fluorescent ornamental fish
#188TRANSGENIC NON-HUMAN ANIMAL AND USES THEREOF
#189Transgenic biosensor
#190Optogenetic control of endothelial cells
#191Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere
#192Optically controlled CNS dysfunction
#193Anti-tumor properties of Dickkopf 3b
#194Biocontrol
#195Normalization of the enterohepatic circulation in animals with a chimeric humanized liver
#196Methods and compositions for the treatment of insulin-associated medical conditions
#197Target molecules for transcriptional control systems
#198Humanized IL-7 rodents
#199IncRNA-knockout mice
#200HAIR FOLLICLE STEM CELLS AND METHODS OF USE SAME
#201ANASTASIS BIOSENSOR
#202TL1A model of inflammation fibrosis and autoimmunity
#203ADAM12 inhibitors and their use against inflammation-induced fibrosis
#204Isolated populations of female germline stem cells and cell preparations and compositions thereof
#205Method and quality control molecular based mouse embryo assay for use with in vitro fertilization technology
#206Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#207Mutant luciferases
#208Rat embryonic stem cell
#209Efficient protein expression in vivo using modified RNA (MOD-RNA)
#210Rodent model of central neuropathic pain caused by dorsal root entry zone avulsion at T13
#211Green transgenic fluorescent ornamental fish
#212Chimeric gene constructs for generation of fluorescent transgenic ornamental fish
#213Stabilized step function opsin proteins and methods of using the same
#214Humanized IL-7 rodents
#215Methods of screening agents for activity using teleosts
#216Efficient sterilization of fish by disruption of germ cell development
#217Polynucleotides comprising a reporter sequence operatively linked to a regulatory element
#218Nucleic acid construct for expression of oxidative stress indicator and use thereof
#219Optically controlled CNS dysfunction
#220Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank
#221Linker for unimolecular FRET biosensor based on principle of fluorescence resonance energy transfer
#222Light-activated chimeric opsins and methods of using the same
#223Model animal for pregnancy-induced hypertension syndrome, and treatment method therefor
#224Transgenic fish and uses thereof
#225Light-sensitive ion-passing molecules
#226Light-sensitive ion-passing molecules
#227METHOD AND SYSTEM FOR MAPPING SYNAPTIC CONNECTIVITY USING LIGHT MICROSCOPY
#228Method for determining genotoxicity using non-fluorescent proteins
#229PROTEIN FRAGMENT COMPLEMENTATION ASSAYS FOR THE DETECTION OF BIOLOGICAL OR DRUG INTERACTIONS
#230Light-sensitive ion-passing molecules
#231NOVEL REPORTER-TAGGED RECOMBINANT MEMBRANE PROTEINS WITH TRANSMEMBRANE LINKERS
#232METHODS OF SCREENING AGENTS FOR ACTIVITY USING TELEOSTS
#233Transgenic biosensors
#234Stem Cell Fusion Model of Carcinogenesis
#235TRANSGENIC ANIMAL OVEREXPRESSING LUCIFERASE AND PREPARATION METHOD THEREOF
#236Chimeric rat produced using rat embryonic stem cells in the presence of an ES cell differentiation suppressant
#237Identification of RNAI targets and use of RNAI for rational therapy of chemotherapy-resistant leukemia and other cancers
#238Fish cancer model
#239Transgenic non-human animal and uses thereof
#240Methods for Screening for Agents that Affect Development
#241Mutant blue fluorescent protein and method of using the same for fluorescence energy transfer and blue fluorescent fish
#242ADAM12 Inhibitors and Their Use Against Inflammation-Induced Fibrosis
#243Islet1 (Isl1) and hearing loss
#244METHODS OF MONITORING ENDOPLASMIC RETICULUM (ER) STRESS RESPONSE
#245DNA capable of inducing osteoblast-specific expression
#246PNMT as a novel marker for progenitor cells
#247Transposition of maize elements in vertebrates
#248Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation
#249Chimeric gene constructs for generation of fluorescent transgenic ornamental fish
#250GENOME EDITING OF GENES INVOLVED IN ADME AND TOXICOLOGY IN ANIMALS
#251GENOMIC EDITING OF GENES INVOLVED IN MACULAR DEGENERATION
#252F1B-TMIR plasmid vector and transgenic mouse
#253Targeted and regional cellular ablation in zebrafish
#254Rat embryonic stem cell
#255Methods for modulating embryonic stem cell differentiation
#256Method for obtaining female germline stem cells and uses thereof
#257TL1A model of inflammation fibrosis and autoimmunity
#258Caveolin 1-reporter protein knock-in mouse
#259Methods for Conditional and Inducible Transgene Expression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
#260METHOD FOR OBSERVING GAD67-POSITIVE CELL IN TRANSGENIC ANIMAL
#261ShRNA gene therapy for treatment of ischemic heart disease
#262Non human transgenic mammal comprising a transgene comprising a nucleotide sequence encoding a ribosomal protein fused to a peptide tag
#263Protein fragment complementation assays for the detection of biological or drug interactions
#264CRUSTACEAN EXPRESSION VECTOR
#265NUCLEAR RECEPTOR SENSOR SYSTEM IN TRANSGENIC ANIMAL
#266THERAPEUTIC AGENT FOR MLL LEUKEMIA AND MOZ LEUKEMIA OF WHICH MOLECULAR TARGET IS M-CSF RECEPTOR, AND USE THEREOF
#267Transgenic fish and uses thereof
#268Oligoribonucleotide inhibitors of Nrf2 and methods of use thereof for treatment of cancer
#269ANIMAL MODEL OF CENTRAL NEUROPATHIC PAIN AND MEHTODS OF MAKING AND USING THE SAME
#270METHODS OF SCREENING AGENTS FOR ACTIVITY USING TELEOSTS
#271TRANSGENIC REPORTER MOUSE AND METHOD FOR USE
#272Targeted delivery of glycine receptors to excitable cells
#273Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
#274TRANSGENIC MAMMALS AND CELL LINES FOR THE IDENTIFICATION OF GLUTAMATE TRANSPORTER MODULATORS
#275Transgenic animal for screening of compounds that modulate cell proliferation, and its use in the pharmaceutical field
#276Compositions and methods for detecting and modulating cell death by a translation regulated gene expression system
#277Method for assessing embryotoxicity
#278PROBE FOR VISUALIZING NEURAL ACTIVITY
#279MK167 mini-promoters
#280METHODS AND COMPOSITIONS FOR TARGETED DELIVERY OF GENE THERAPEUTIC VECTORS
#281Mutant blue fluorescent protein and method of using the same for fluorescence resonance energy transfer and blue fluorescent fish
#282METHOD FOR DISTINGUISHING SECRETORY GRANULES OF DIFFERENT AGES
#283TRIPLE TRANSGENIC MOUSE MODEL OF AUTOIMMUNE DISEASE AND NF-KAPPA B IN VIVO IMAGING
#284Transgenic animal with monocyte chemotactic protein 1 promoter
#285CLDN5 mini-promoters
#286Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged Tissue
#287Methods of identifying inhibitors of gene silencing in mammalian cells
#288Animal Model of Synovial Sarcoma
#289Methods for introducing a human gene into a marmoset embryo for making a transgenic marmoset
#290HEAT SHOCK PROTEIN DEFICIENCIES AS MODEL SYSTEMS FOR BRAIN PATHOLOGY AND CANCER
#291IMAGEABLE RODENT MODEL OF ASTHMA
#292METHODS FOR IDENTIFICATION AND SELECTION OF HUMAN EMBRYONIC STEM CELL DERIVED CELLS
#293F1B-TMIR plasmid vector and transgenic mouse
#294STG Promoter And Its Use As A Marker For Taste And Oocyte Cells
#295Intracellular pH sensor using nucleic acid assemblies
#296TUMOR SUPPRESSOR GENE SCREENING USING RNA INTERFERENCE LIBRARIES AND METHOD OF TREATMENT
#297Synthetic 5'UTRs, expression vectors, and methods for increasing transgene expression
#298Transgenic Zebrafish Models for Neurodegenerative Diseases
#299METHOD OF SCREENING PTP ZETA ACTIVITY PROMOTER OR INHIBITOR
#300Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis